您好,欢迎访问中国热带农业科学院 机构知识库!

Novel mangiferin derivatives attenuate adipogenesis in 3T3-L1 preadipocytes and ameliorate diet induced obesity in C57BL/6J mice

文献类型: 外文期刊

作者: Gu, Dong-Quan 1 ; Li, Yin 1 ; Wu, Liu-Shun 1 ; Lyu, Meng-Ting 1 ; Li, Ying 1 ; Huang, Sheng-Zhuo 4 ; Xu, Feng-Qing 1 ; Wu, De-Ling 1 ; Zhou, Wu-Xi 1 ;

作者机构: 1.Anhui Univ Chinese Med, Sch Pharm, Hefei 230012, Peoples R China

2.Anhui Prov Key Lab Bioact Nat Prod, Hefei 230012, Peoples R China

3.Anhui Prov Key Lab New Mfg Technol Tradit Chinese, Hefei 230012, Peoples R China

4.Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Res & Dev Nat Prod Li Folk Med Hainan Prov, Haikou 571101, Peoples R China

期刊名称:RSC MEDICINAL CHEMISTRY ( 影响因子:3.6; 五年影响因子:4.2 )

ISSN:

年卷期: 2025 年

页码:

收录情况: SCI

摘要: Mangiferin with a xanthone scaffold exhibited potent anti-obesity activities and thus has attracted interest. However, some shortcomings, including limited solubility and moderate potency, restrict its application. To develop novel and efficient anti-obesity agents, a series of mangiferin (MGF) amino acid derivatives were synthesized, optimized and evaluated for anti-obesity activities in vitro and in vivo. Among these derivatives, G1 was identified to be a promising compound. G1 showed better liposolubility compared to MGF. In 3T3-L1 preadipocytes, G1 significantly inhibited cell differentiation and reduced fat accumulation by increasing inhibitory activity on fatty acid synthase, and triggering G0/G1 phase cell cycle arrest and production of intracellular reactive oxygen species. The intraperitoneal administration of G1 (30, 60 mg kg-1/2 days) significantly inhibited body, liver and fat tissue weight gain, reduced lipid dysfunction, and ameliorated pathological characteristics in high-fat diet induced C57BL/6J obese mice. These results suggest that compound G1 may warrant further investigation as a promising anti-obesity agent for the treatment of human obesity.

  • 相关文献
作者其他论文 更多>>